While multiple sclerosis (MS) disproportionately affects Whites of European descent, recent studies suggest an increasing rate among minority patient populations, including African and Hispanic Americans, compared to Caucasian Americans. Studies have shown ethnic differences in the characteristics, progression, and incidence of the disease, including greater disability at diagnosis and diagnostic delays compared to Caucasians. Because minority groups have been historically underrepresented in clinical trials, there has been a paucity of data in these populations. In this Clinical Transfers® activity, Drs. Mitzi Williams and Lilyana Amezcua will dive deeper into these topics, exploring the racial and ethnic variability in MS and disparities in care.
Upon completion of this activity, participants should be better able to:
Neurologist and Multiple Sclerosis Specialist
Founder and Medical Director, Joi Life Wellness Group
Associate Professor, Neurology
Director, Multiple Sclerosis Fellowship Program
Multiple Sclerosis Comprehensive Care and Research Group
USC, Keck School of Medicine
Los Angeles, CA
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy.
Lilyana Amezcua, MD, MS, FAAN, has relevant financial relationships with Biogen Idec, EMD Serono, Genentech, Novartis, Sanofi Genzyme (Consultant); Bristol Myers Squibb Foundation, Genentech, Sanofi Genzyme (Grant/Research Support).
Mitzi Joi Williams, MD, has relevant financial relationships with EMD Serono, Genentech, Novartis (Researcher); Alexion, Biogen Idec, Bristol Myers Squibb, EMD Serono, Genentech, Janssen, Novartis, Sanofi Genzyme, TG Therapeutics (Consultant); Alexion, Biogen Idec, Bristol Myers Squibb, EMD Serono, Genentech, Janssen, Novartis, Sanofi Genzyme, TG Therapeutics (Advisor); Biogen Idec, Bristol Myers Squibb, EMD Serono, Genentech, Janssen, Novartis, Sanofi Genzyme (Speaker/ Speaker’s Bureau).
All of the relevant financial relationships listed for these individuals have been mitigated according to RMEI policies.
In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
RMEI Medical Education, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hour(s).
In order to receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. A statement of credit will be available to print immediately. You must score 80% or higher on the post-test to receive credit for this activity. If you have questions about this activity, please contact RMEI at [email protected].
There is no fee to participate.
COMPLETE THE EVALUATION FORM AND YOU WILL BE ENTERED INTO A DRAWING
FOR A $100* AMAZON GIFT CARD!
*The expense for this gift card is solely funded by RMEI Medical Education, LLC.
No supporter funding was used for the expense of this gift card.
Rules and Regulations
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources